THE ROLE OF MAJOR AND MINOR HISTOCOMPATIBILITY ANTIGENS IN ACTIVE ENHANCEMENT OF RAT-KIDNEY ALLOGRAFT SURVIVAL BY BLOOD-TRANSFUSION

Rats given a blood transfusion do not reject a subsequent kidney allograft from the same donor strain. This effect is strain-specific so that pretransplant blood transfusion from a LEW (RT11) rat will protect a LEW kidney in a DA (RT1a) recipient but not a PVG/c (RT1c) kidney. The same is true in other combinations. Using DA or PVG.RT1a congenic recipients we have shown that sharing of all or part of the MHC or of minor alloantigens by the blood transfusion and kidney transplant donors is sufficient to prolong allograft survival. Activation of suppression against minor alloantigens appears to require two signals: one is the minor alloantigen and the other may be a major histocompatibility complex alloantigen.